UNSPSC 51201825: Betazole hydrochloride

This classification denotes a diagnostic reagent with the molecular formula C5H9N3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66ABP6C83F, chemically known as 3,5-beta-pyrazoleethylamine dihydrochloride but more generally known as betazole hydrochloride, which bears US NIH Compound Identifier 67412. The base compound, betazole, most often comes in base, dihydrochloride, and hydrochloride forms.

UNSPSC 51201825 Betazole hydrochloride is a Commodity code that in recent state and local procurement activity covers pharmaceutical products including vaccines and diagnostic agents. The recent opportunity posted under this code shows the Mississippi State Department of Health soliciting Yellow Fever Vaccine from a single source, though the code's nominal scope (betazole hydrochloride, a gastric stimulant agent) and the actual solicitation (a vaccine) do not align. State and local health departments and public health agencies appear to be the primary issuing bodies using this code, though the single recent opportunity provides limited visibility into the broader issuing-body pattern.

The Mississippi State Department of Health posted a sole source procurement notice (Solicitation Number 3150006922, due August 3, 2026 at 10:00 a.m. CST) for Yellow Fever Vaccine, with objections to the sole source designation accepted through that same deadline. The notice does not specify quantity, contract term, estimated value, or pricing. The mismatch between the code's pharmaceutical name and the vaccine solicitation suggests either a coding error in the state's procurement system or a broader tagging practice that does not strictly adhere to UNSPSC definitions at the commodity level. Recent activity under this code is minimal and geographically limited to Mississippi.